NSE Closed
Markets
NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%HDFCBANK7530.65%BHARTIARTL1,970.50.08%INFY1,1804.42%TCS2,473.74.57%NIFTY 5024,774.31.60%NIFTY BANK58,247.951.72%NIFTY IT31,715.253.28%NIFTY FIN SERVICE26,984.451.47%INDIA VIX11.870.94%SENSEX78,639.030.70%LT4,0252.19%ICICIBANK1,4601.71%SBIN1,0451.71%ADANIENT3,0681.94%BAJFINANCE1,1531.03%RELIANCE1,3190.86%ITC2872.14%HDFCBANK7530.65%BHARTIARTL1,970.50.08%INFY1,1804.42%TCS2,473.74.57%
HomeSymbolMARKSANS

Marksans Pharma Limited

NSE · MARKSANS · marksanspharma.com
₹262.25
Last close · NSE/BSE
Set alert
Fundamentals
Mkt Cap
₹11,884.22 Cr
52W High
₹281.6
52W Low
₹155
P/E
80.2
EPS
₹3.27
Book Value
₹66.71
ROE
0.14%
ROCE
20.19%
ROA
0.11%
Profit margin
0.14%
Debt/Equity
0.11
P/B
3.93
Div Yield
0.00%
Rev. growth
20.46%
Sector
Pharmaceuticals
Ratios
Debtor days
75.2
Inventory days
117.7
Payable days
42.5
Cash conversion
150.3
Working cap. days
192.8
Interest coverage
44.2×
Dividend payout
Technicals · Members only

Unlock the technical read on $MARKSANS — RSI, MACD, moving averages and intraday pivot levels — free when you sign in.

  • RSI, MACD & trend strength (ADX)
  • Price vs 20/50/100/200-day averages
  • Support & resistance pivot levels
Sign in to unlock — freeCreate an account
Premium market data is free for bulls.plus members — just sign up and verify your email. For information only — not investment advice.
Shareholding · 2026-06
Promoter 43.87%FII 17.47%DII 6.19%Public 32.47%Pledge 0.00%Shareholders 2,46,635
Shareholding pattern
Jun 26Mar 26Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24
Promoter43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.87%43.85%
FII17.47%16.76%8.12%16.92%19.88%22.20%21.96%21.31%18.60%15.57%
DII6.19%6.57%5.91%5.28%5.50%4.56%4.30%4.10%3.75%5.17%
Public32.47%32.79%42.09%33.93%30.75%29.37%29.87%30.71%33.78%35.40%
Others4.42%4.45%13.11%4.40%4.00%3.59%3.63%3.95%4.31%4.49%
No. of shareholders2,46,6352,46,2792,55,1532,65,7882,56,2212,57,2732,59,8132,48,8452,35,5002,54,699
Quarterly SEBI shareholding filings (CMOTS). Latest 10 of 42 quarters shown.
Financials
₹ CrFY26FY25FY25FY25FY25FY25FY24
Revenue₹361.57₹339.73₹320.44₹319.73₹299.36₹2,693.22₹311.87
EBIT₹124.71₹82.47₹121.81₹63.88₹50.21₹515.63₹75.03
PBT₹503.97
Net Profit₹91.92₹60.91₹99.81₹48.06₹37.59₹380.58₹55.46
EPS (₹)₹8.4
Figures in ₹ crore · CMOTS fundamentals via api.ipo.plus
Company details
Mark SaldanhaChairman & Managing Director
Harshavardhan PanigrahiCompany Sec. & Compli. Officer
Sandra SaldanhaWhole-time Director
Digant Mahesh ParikhIndependent Director
Varddhman Vikramaditya JainWhole-time Director
Abhinna Sundar MohantyIndependent Director
Sunny SharmaNon Executive Director
Shailaja VardhanIndependent Director
Srinivas MishraIndependent Director
Corporate actions
forthcoming Dividend (0.9/- per share)Ex 2026-08-20
dividend ₹0.9 (90%)Ex 2026-08-20
forthcoming Board MeetingsEx 2026-08-12
dividend ₹0.8 (80%)Ex 2025-08-01
Community sentiment · No signal
How do you feel about $MARKSANS? · 0 bull · 0 bear
Message volume
0
Quiet · 0 in 24h
Participation
· 0 accounts
Sentiment trend (30d)
Not enough history yet — building the sentiment trend.

$MARKSANS · Community

0 posts
No posts in $MARKSANS yet. Start the conversation.